Clinical Trials Directory

Trials / Terminated

TerminatedNCT02227329

Prophylactic Ethanol Lock Therapy (ELT) in Patients on Home Parenteral Nutrition

Prophylactic Ethanol Lock Therapy (ELT) in Patients on Home Parenteral Nutrition: A Prospective Randomized Control Trial.

Status
Terminated
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
39 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This study is being implemented to identify the role of prophylactic use of ethanol lock in adult patients on home parenteral nutrition (HPN). Central catheter related blood stream infection is a major complication in patients on HPN. The investigators hypothesize that the prophylactic use of ELT will decrease the number of catheter related blood stream infections compared to the control group. The investigators further hypothesize that with the introduction of prophylactic ELT, the number of infections will decrease.

Detailed description

Catheter-related bloodstream infection (CRBSI) is a serious complication for home parenteral nutrition (HPN) patients causing morbidity, mortality, and prolonged hospitalization. CRBSIs may also result in the need for central venous catheter (CVC) removal and replacement. Current literature supports the use of antibiotics locks in patients with repeated CRBSI. There is a growing concern about the increased risk of microbial resistance with the long term use antibiotic locks. Ethanol lock therapy (ELT) has broad spectrum coverage and includes gram negative bacteria, gram positive bacteria, atypical bacteria, and fungi. Compared with antibiotic and other solution locks, which have limitations, ELT has excellent broad-spectrum bactericidal and fungicidal killing action and poses no problems with development of resistance over time. There is a lack of a randomized controlled study to characterize the role of ELT in adult patients on HPN.

Conditions

Interventions

TypeNameDescription
DRUGEthanolProphylactic ELT will be administered at the time when the HPN is not being infused.
DRUGHeparin Lock3 mL of 100 U/ml heparin
DRUGNormal Saline

Timeline

Start date
2014-07-01
Primary completion
2016-10-01
Completion
2016-10-01
First posted
2014-08-28
Last updated
2017-12-12
Results posted
2017-12-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02227329. Inclusion in this directory is not an endorsement.